Quality
F.D.A. Faces Community Backlash Over Drug Denials
The U.S. Food and Drug Administration (F.D.A.) has been at the forefront of public health initiatives, playing a critical role in ensuring drug safety and efficacy. Recent events, however, have spotlighted the agency amid a storm of public dissent and policy scrutiny. At the center of this controversy is the F.D.A.’s decision to reject several […]
Read more →